Wolfram Goessling

Wolfram Goessling

Harvard University

H-index: 51

North America-United States

About Wolfram Goessling

Wolfram Goessling, With an exceptional h-index of 51 and a recent h-index of 39 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Developmental Biology, Liver Regeneration, Liver Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Corrigendium: Effects of RAS on the genesis of embryonal rhabdomyosarcoma

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

Treatment of liver injury

Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival

Abstract C057: Fibrolamellar carcinoma single-nucleus RNA sequencing reveals alteration of mitochondrial energetic pathways

Blood Flow Directs Yap/Taz-Mediated Transcriptional Regulation of Self-Renewal Programs to Control Developmental HSPC Expansion By Mechanical Stimulation of Piezo1

Wolfram Goessling Information

University

Position

Professor of Medicine, Harvard Medical School

Citations(all)

14889

Citations(since 2020)

6584

Cited By

11164

hIndex(all)

51

hIndex(since 2020)

39

i10Index(all)

94

i10Index(since 2020)

82

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Wolfram Goessling Skills & Research Interests

Developmental Biology

Liver Regeneration

Liver Cancer

Top articles of Wolfram Goessling

Title

Journal

Author(s)

Publication Date

Corrigendium: Effects of RAS on the genesis of embryonal rhabdomyosarcoma

Genes & Development

David M Langenau

Matthew D Keefe

Narie Y Storer

Jeffrey R Guyon

Jeffery L Kutok

...

2024/3/1

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for Immunotherapy of Cancer

Brandon M Huffman

Harshabad Singh

Lestat R Ali

Nora Horick

S Jennifer Wang

...

2024

A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis

Hepatology Communications

Marc S Sherman

Prasanna K Challa

Eric M Przybyszewski

Robert M Wilechansky

Eugenia N Uche-Anya

...

2024/4/1

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

The Oncologist

Kimberly Perez

Anna M Chiarella

James M Cleary

Nora Horick

Colin Weekes

...

2023/5/1

Treatment of liver injury

2023/2/23

Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival

Biorxiv

Constantine N Tzouanas

Marc S Sherman

Jessica ES Shay

Adam J Rubin

Benjamin E Mead

...

2023/12/1

Abstract C057: Fibrolamellar carcinoma single-nucleus RNA sequencing reveals alteration of mitochondrial energetic pathways

NaN

Nihal Bharath

Biju Isaac

Marc S Sherman

Colton J Smith

Michael Karski

...

2023

Blood Flow Directs Yap/Taz-Mediated Transcriptional Regulation of Self-Renewal Programs to Control Developmental HSPC Expansion By Mechanical Stimulation of Piezo1

Blood

Wade W Sugden

Zachary LeBlanc

Mayuri Tanaka-Yano

Ran Jing

Maria Gonzalez di Tillio

...

2023/11/28

2006–MECHANISMS OF FLOW-DRIVEN TRANSCRIPTIONAL CONTROL OF HEMATOPOIETIC STEM AND PROGENITOR CELL DEVELOPMENT BY YAP AND TAZ

Experimental Hematology

Wade Sugden

Zachary LeBlanc

Mayuri Yano

Caroline Kubaczka

Rubul Mout

...

2023/1/1

SARS-CoV-2 viral liver aggregates and scarce parenchymal infection implicate systemic disease as a driver of abnormal liver function

Hepatology Communications

Brian J Pepe-Mooney

Colton J Smith

Marc S Sherman

Trista E North

Robert F Padera Jr

...

2023/11/1

Biliary epithelial cells are facultative liver stem cells during liver regeneration in adult zebrafish

JCI insight

Isaac M Oderberg

Wolfram Goessling

2023/1/1

Acyl-CoA thioesterase 12 suppresses YAP-mediated hepatocarcinogenesis by limiting glycerolipid biosynthesis

Cancer Letters

Haiyue He

Akiko Sugiyama

Nathaniel W Snyder

Marcos G Teneche

Xiaowei Liu

...

2023/7/1

97: MATHEMATICAL MODELING PREDICTS BOTH RESOLUTION AND PERSISTENCE OF LIVER INJURY INDEPENDENT OF ABSOLUTE SERUM TRANSAMINASE LEVEL, ENABLES REAL-TIME ESTIMATION OF ACTIVE …

Gastroenterology

Marc Sherman

Wolfram Goessling

2022/5/1

Embryonic alcohol exposure disrupts the ubiquitin-proteasome system

JCI insight

Olivia Weeks

Bess M Miller

Brian J Pepe-Mooney

Isaac M Oderberg

Scott H Freeburg

...

2022/12/12

Su1388: NATURAL LANGUAGE PROCESSING ENABLES HIGHLY ACCURATE EXTRACTION OF DETAILED HISTOPATHOLOGIC FEATURES OF NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS FROM PATHOLOGY REPORTS

Gastroenterology

Marc Sherman

Prasanna Kumar Challa

Ashley T Ott

Eric M Przybyszewski

Eugenia Uche Anya

...

2022/5/1

Bnip3lb Regulated Mitophagy Maintains the Embryonic Pool of Hematopoietic Stem Cells by Protecting Them from ROS Induced Apoptosis

Blood

Eleanor Meader

Paul J Wrighton

Isaac Oderberg

Mindy Leder

Morgan Walcheck

...

2022/11/15

Tu1252: AN ENHANCED TOOLKIT FOR THE ALGORITHMIC DETECTION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A MULTI-HOSPITAL HEALTHCARE SYSTEM

Gastroenterology

Ashley T Ott

Wolfram Goessling

Marc Sherman

2022/5/1

osr1 Maintains Renal Progenitors and Regulates Podocyte Development by Promoting wnt2ba via the Antagonism of hand2

Biomedicines

Bridgette E Drummond

Brooke E Chambers

Hannah M Wesselman

Shannon Gibson

Liana Arceri

...

2022/11/9

YAP—deLIVERing the directions and the fuel

Developmental Cell

Scott H Freeburg

Wolfram Goessling

2022/3/28

Cap CASP, not SCAP, to fight steatohepatitis

Cell Metabolism

Wolfram Goessling

2022/10/4

See List of Professors in Wolfram Goessling University(Harvard University)

Co-Authors

H-index: 139
George Q. Daley MD, PhD

George Q. Daley MD, PhD

Harvard University

H-index: 128
Sangeeta N. Bhatia

Sangeeta N. Bhatia

Massachusetts Institute of Technology

H-index: 43
Claudia Lengerke

Claudia Lengerke

Universität Basel

H-index: 40
Trista E North

Trista E North

Harvard University

H-index: 39
Ignaty Leshchiner

Ignaty Leshchiner

Harvard University

H-index: 29
Stephen Zucker

Stephen Zucker

Harvard University

academic-engine